Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 142 publications.
Herring WL, Zhang Y, Pearson I, Tempest M, Freudensprung U, Acosta C, Hyde R, Spelman T, Butzkueven H. A cost-effectiveness analysis using real-world data from the MSBase registry: comparing natalizumab to fingolimod in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple sclerosis (RRMS) in Scotland. Poster presented at the 2018 American Academy of Neurology Annual Meeting; April 22, 2018. Los Angeles, CA. Previously presented at the 7th Joint ECTRIMS-ACTRIMS Meeting.
Boudewyns V, Southwell BG, Betts KR, Slota Gupta C, Paquin RS, O’Donoghue AC, Vazquez N. Awareness of misinformation in health-related advertising: a narrative review of the literature. In: Southwell BG, Thorson EA, Sheble L, editors. Misinformation and mass audiences. 1st ed. Austin: TX. University of Texas Press; 2018. p.35-50.